| 5133 |
Centers for Disease Control and Prevention |
Html |
en |
Ehrlichiosis |
Information on disease caused by Ehrlichiosis. Provided by the U.S. Centers for Disease Control and Prevention. |
| Big Disease | 0.50703 |
| Ehrlichia species | 0.738439 |
| United States | 0.73358 |
| MMWR Recommendations | 0.503537 |
| Ehrlichia ewingii | 0.840487 |
| adults | 0.417912 |
| Patient Diagnosis | 0.509361 |
| Anaplasmosis | 0.433793 |
| Tickborne Illnesses | 0.618695 |
| line treatment | 0.51193 |
| COCA call—Little Bite | 0.644161 |
| Free CE | 0.601866 |
| Typical symptoms | 0.519241 |
| fatigue | 0.422162 |
| Mountain Spotted Fever | 0.631648 |
| children | 0.417894 |
| infected tick | 0.566656 |
| muscle aches | 0.537476 |
| Tickborne Rickettsial Diseases | 0.92141 |
| tickborne diseases | 0.627669 |
|
| Amblyomma americanum | 0.548638 |
| Human ehrlichiosisis | 0.53055 |
| primary vector | 0.518759 |
| animals | 0.421114 |
| Ehrlichioses | 0.433846 |
| different ehrlichial species | 0.637946 |
| Borrelia miyamotoi | 0.618238 |
| Ehrlichia chaffeensis | 0.841125 |
| Medscape Expert Commentary | 0.611645 |
| Management | 0.433273 |
| Ehrlichiae | 0.419398 |
| Spotted Fever Group | 0.631047 |
| bacterial diseases | 0.539781 |
| clinical presentation | 0.513507 |
| tick bite | 0.598126 |
| lone star | 0.520989 |
| ages | 0.417867 |
| specialized laboratory tests | 0.608094 |
| headache | 0.42372 |
|
CLICK HERE |
| 6095 |
Centers for Disease Control and Prevention |
Html |
en |
n-Butyl acetate - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 10011 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Using the Program Sustainability Assessment Tool to Assess and Plan for Sustainability - CDC |
Implementing and growing a public health program that benefits society takes considerable time and effort. To ensure that positive outcomes are maintained over time, program managers and stakeholders should plan and implement activities to build sustainability capacity within their programs. We describe a 3-part sustainability planning process that programs can follow to build their sustainability capacity. |
| Prevention program sustainability | 0.586973 |
| sustainability efforts | 0.56609 |
| program | 0.860486 |
| summary Sustainability Report | 0.614518 |
| sustainability indicators | 0.542774 |
| sustainability planning process | 0.718048 |
| chronic disease program | 0.584026 |
| Public Health Systems | 0.497019 |
| ongoing sustainability assessment | 0.552865 |
| long-term sustainability | 0.566029 |
| sustainability capacity | 0.940747 |
| sample Sustainability Report | 0.569924 |
| PSAT summary Sustainability | 0.624678 |
| program sustainability planning | 0.647056 |
| sustainability scores | 0.55584 |
| 3-part sustainability | 0.564393 |
| sustainability | 0.997386 |
| sustainability measurement tools | 0.58209 |
| St Louis | 0.492778 |
| sustainability factors | 0.53373 |
| sustainability planning | 0.72339 |
| sustainability needs | 0.56274 |
| current sustainability strengths | 0.553979 |
| sustainability results | 0.545014 |
|
| Health Systems Science | 0.492495 |
| program’s sustainability | 0.703037 |
| long-term sustainability efforts | 0.563214 |
| program sustainability capacity | 0.64758 |
| sustainability planning model | 0.557987 |
| Program Sustainability Assessment | 0.745505 |
| priority sustainability areas | 0.560802 |
| program managers | 0.509047 |
| health program capacity | 0.513959 |
| program staff | 0.565211 |
| public health | 0.684792 |
| public health program | 0.595561 |
| Sustainability Assessment Tool | 0.72153 |
| sustainability domains | 0.548488 |
| sustainability planning resources | 0.563963 |
| public health programs | 0.611759 |
| sustainability action planning | 0.627504 |
| program’s capacity | 0.490903 |
| action steps | 0.5598 |
| health department program | 0.494614 |
| Sustainability Report | 0.635598 |
| current sustainability capacity | 0.594095 |
| G. Coalition sustainability | 0.54424 |
| Sustainability Framework | 0.572135 |
|
CLICK HERE |
| 11200 |
Centers for Disease Control and Prevention |
Html |
en |
Diagnosis | Ebola Hemorrhagic Fever |
null |
| detectable levels | 0.651505 |
| patients | 0.37363 |
| typhoid fever | 0.779545 |
| Ebola infection | 0.909831 |
| malaria | 0.401032 |
| blood | 0.363548 |
| public health authorities | 0.936638 |
| Ebola virus | 0.841318 |
|
| Laboratory tests | 0.619375 |
| person | 0.489185 |
| patient | 0.43284 |
| Samples | 0.367765 |
| contact | 0.366885 |
| common diseases | 0.672141 |
| early symptoms | 0.906326 |
|
CLICK HERE |
| 11377 |
Centers for Disease Control and Prevention |
Html |
en |
Ethylene Oxide (EtO): Evidence of Carcinogenicity (81-130) |
null |
| Swedish EtO production | 0.543423 |
| ethylene oxide workers | 0.527748 |
| Airborne Ethylene Oxide | 0.487886 |
| EtO area | 0.528577 |
| Health Industry Manufacturers | 0.480646 |
| Ethylene Oxide One-Generation | 0.493974 |
| Industry Manufacturers Association | 0.475092 |
| Ethylene Oxide Two-year | 0.493578 |
| control groups | 0.466194 |
| ethylene dichloride | 0.465414 |
| worker exposure | 0.498918 |
| Ethylene Oxide Production | 0.500069 |
| Ethylene Oxide Containing | 0.492803 |
| NIOSH | 0.471925 |
| EtO exposure | 0.667763 |
| HIMA Report No. | 0.490555 |
| Ethylene Oxide Monitoring | 0.489049 |
| Ethylene Oxide Neurotoxicity | 0.49308 |
| Environmental Protection Agency | 0.484081 |
| EtO production area | 0.544413 |
| experiment EtO | 0.516977 |
| female rats | 0.4742 |
| Ethylene Oxide Administered | 0.493893 |
| carcinogenic potential | 0.46628 |
| EtO vapor | 0.539313 |
|
| EtO concentrations | 0.538131 |
| Reactive Ethylene Derivatives | 0.46085 |
| U.S. Environmental Protection | 0.462665 |
| occupational exposure | 0.480695 |
| Governmental Industrial Hygienists | 0.462195 |
| ethylene oxide | 0.917502 |
| 14C-labelled EtO | 0.521455 |
| ethylene glycol | 0.464026 |
| public health | 0.466976 |
| health care | 0.46435 |
| potential occupational carcinogen | 0.461755 |
| EtO | 0.744487 |
| EtO workers | 0.539415 |
| EtO consumption | 0.533142 |
| Ethylene Oxide Exposures | 0.489176 |
| mononuclear cell leukemia | 0.53934 |
| potential EtO exposure | 0.564476 |
| OSHA standard | 0.477035 |
| ppm | 0.470221 |
| NIOSH Occupational Exposure | 0.461978 |
| airborne EtO | 0.525131 |
| EtO manufacturers | 0.525317 |
| total EtO | 0.526502 |
| Ethylene Oxide Technical | 0.492968 |
|
CLICK HERE |
| 11810 |
Centers for Disease Control and Prevention |
Html |
en |
FAQ: Flu Vaccines & Preventing Flu Illness |
Frequently Asked Questions (FAQ) about flu vaccines and preventing flu illness - CDC |
| Influenza Diagnostic Testing | 0.479358 |
| Flu Illness | 0.691279 |
| Flu Viruses | 0.627184 |
| flu vaccines | 0.85885 |
| Vaccine Benefits | 0.482141 |
| Prevent Flu | 0.636593 |
| Influenza Testing Results | 0.502879 |
| Flu Good Health | 0.62402 |
| Influenza Viruses | 0.501226 |
| Seasonal Influenza Vaccine | 0.697241 |
| Quadrivalent Influenza Vaccine | 0.600071 |
| Flu Adults | 0.606674 |
| Flu Activity | 0.597036 |
| Influenza Pandemic Virus | 0.487684 |
| (Flu) | 0.767059 |
| Preventing Flu Illness | 0.656695 |
| ) Vaccination | 0.704341 |
| Influenza Vaccines | 0.531976 |
| United States Flu | 0.614237 |
| Vaccine Safety Vaccine | 0.598583 |
| Influenza Viruses Types | 0.498257 |
| Flublok Seasonal Influenza | 0.503104 |
| Vaccine Supply | 0.488156 |
| Vaccination Flu Vaccination | 0.656285 |
| High-Dose Seasonal Influenza | 0.504046 |
|
| Weekly U.S. Influenza | 0.479553 |
| Flu Antiviral Drugs | 0.72964 |
| flu vaccine | 0.992179 |
| Seasonal Flu Vaccine | 0.714172 |
| CDC International Flu | 0.610271 |
| flu vaccine work | 0.712638 |
| Prevent Flu Preventive | 0.619012 |
| Flu Vaccine Recommendation | 0.716319 |
| Flu Treatment | 0.611132 |
| Influenza Vaccine | 0.70206 |
| Influenza Vaccination Clinic | 0.497499 |
| Flu News | 0.570521 |
| Flu Complications | 0.588384 |
| Flu Season Flu | 0.920142 |
| Diagnosis Flu Symptoms | 0.61933 |
| Flu Vaccine Safety | 0.762066 |
| Cell-Based Flu Vaccines | 0.656573 |
| Flu Season Current | 0.63425 |
| Vaccine Effectiveness | 0.518553 |
| Flu Vaccines Work | 0.665783 |
| Influenza Vaccine Advances | 0.566995 |
| Influenza Vaccine Doses | 0.597202 |
| Past Flu Seasons | 0.621465 |
| Influenza 2015-2016 Season | 0.496302 |
|
CLICK HERE |
| 12104 |
Centers for Disease Control and Prevention |
Html |
en |
Lung Cancer |
Lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States. |
| lung cancer screening | 0.737337 |
| Basic Information | 0.466932 |
| United States | 0.475014 |
| naturally occurring gas | 0.52905 |
| cause | 0.426897 |
| possible benefits | 0.464919 |
| LDCT | 0.410906 |
| cell phone | 0.468836 |
| blog | 0.41035 |
| substitute | 0.41469 |
| QUIT-NOW | 0.411492 |
| lung cancer | 0.918858 |
| lung cancer images | 0.638652 |
| Early Detection | 0.461251 |
| common cancer | 0.486837 |
| rocks | 0.411651 |
| smoking | 0.426851 |
| podcast | 0.411071 |
| harms | 0.415635 |
| CDC Expert Commentary | 0.514193 |
| visit smokefree.gov | 0.468572 |
| text | 0.411463 |
|
| secondhand smoke | 0.475292 |
| non-smoker shares | 0.471159 |
| low-dose computed tomography | 0.537584 |
| important thing | 0.474952 |
| Household | 0.410274 |
| dirt | 0.411036 |
| People | 0.411009 |
| QUIT | 0.419362 |
| Talk | 0.410821 |
| Medscape | 0.414725 |
| home | 0.411706 |
| lung cancer risk | 0.680331 |
| lung cancer deaths | 0.635877 |
| doctor | 0.410807 |
| help | 0.411545 |
| social network profile | 0.514632 |
| Promising Time | 0.470042 |
| buildings | 0.411204 |
| Radon promising practices | 0.546549 |
| Web site | 0.462587 |
| women | 0.412465 |
|
CLICK HERE |
| 12308 |
Centers for Disease Control and Prevention |
Html |
en |
Seasonal Influenza Vaccine Effectiveness, 2005-2015 |
Seasonal Influenza Vaccine Effectiveness, 2005-2015 - CDC |
| seasonal flu vaccination | 0.617034 |
| public health intervention | 0.524333 |
| Donahue JG,et al | 0.516913 |
| McLean HQ | 0.512031 |
| respiratory illness visits | 0.51033 |
| inactivated influenza vaccines | 0.588712 |
| laboratory-confirmed influenza infections | 0.587245 |
| flu vaccines | 0.555266 |
| Thompson MG | 0.509489 |
| laboratory-confirmed flu | 0.543552 |
| prior vaccination | 0.467838 |
| observational studies | 0.530055 |
| Flu VE Network | 0.567234 |
| seasonal influenza vaccines | 0.56562 |
| Network sites measure | 0.517249 |
| Flu Vaccine Effectiveness | 0.709462 |
| 534-543. doi | 0.480342 |
| laboratory-confirmed influenza infection | 0.585646 |
| Kieke BA | 0.51536 |
| study design | 0.470789 |
| Jackson ML | 0.511121 |
| Clin Infect Dis. | 0.510665 |
| 319-27. doi | 0.47942 |
| vaccine effectiveness | 0.94952 |
| Belongia EA | 0.654737 |
|
| influenza vaccine effectiveness | 0.841578 |
| Infect Dis. | 0.582357 |
| Epub | 0.504238 |
| 159-67. doi | 0.48705 |
| Print-friendly Version PDF | 0.516671 |
| doi | 0.489002 |
| Petrie JG | 0.525021 |
| United States | 0.576742 |
| 6558-63. doi | 0.486418 |
| accurate lab test | 0.512915 |
| Ohmit SE | 0.572181 |
| laboratory-confirmed influenza | 0.603391 |
| acute respiratory illness | 0.704026 |
| Study results | 0.470228 |
| non-adjuvanted pandemic influenza | 0.575101 |
| outpatient medical visits | 0.51207 |
| vaccine strains | 0.502456 |
| influenza seasons | 0.529258 |
| ACIP meeting | 0.466362 |
| Nowalk MP | 0.515067 |
| e23085. doi | 0.48362 |
| et al | 0.636028 |
| flu season | 0.581918 |
| PMID | 0.470761 |
|
CLICK HERE |
| 12724 |
Centers for Disease Control and Prevention |
Video |
en |
Why Surveillance Matters |
No country is absolutely safe from disease, even deadly diseases not found in the US. Vigilance is needed and that's why CDC works 24/7 to protect America's Health Security.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at http://streaming.cdc.gov/vod.php?id=8cd51ff603806c6a5ecadd975d66757d20131209111531484 |
| Surveillance Matters | 0.937221 |
|
|
CLICK HERE |
| 13833 |
Centers for Disease Control and Prevention |
Html |
en |
Announcement: World Pneumonia Day - November 12,2015 |
November 12, 2015, is the seventh annual World Pneumonia Day, observed to raise awareness and promote interventions to protect against, treat, and prevent pneumonia, which continues to be a global public health concern. Each year approximately 900,000 children aged <5 years die from pneumonia worldwide; 70% of childhood pneumonia hospitalizations in the United States are in this age group (1,2). Pneumonia is also a leading infectious cause of hospitalization and death among U. |
| pneumonia worldwide | 0.861172 |
| Diarrhea Progress Report | 0.718002 |
| Human Services | 0.719729 |
| Wier LM | 0.628346 |
| Engl J Med | 0.631207 |
| U.S. Department | 0.722448 |
| MMWR HTML versions | 0.71333 |
| childhood pneumonia hospitalizations | 0.981201 |
| Statistical Brief No. | 0.712238 |
| post-2015 priorities | 0.619019 |
| electronic PDF version | 0.700959 |
| U.S. children | 0.64176 |
| future pneumonia-related deaths | 0.730787 |
| additional information | 0.737977 |
| national governments | 0.620808 |
| new Pneumonia | 0.823523 |
| diagnostic tests | 0.625108 |
| Contact GPO | 0.634933 |
| U.S. government agencies | 0.747261 |
| hospital stays | 0.61791 |
| hospital expenses | 0.633892 |
| national causes | 0.620852 |
| global partners | 0.632642 |
| private sector | 0.616052 |
|
| global public health | 0.77378 |
| original paper copy | 0.706134 |
| medical conditions | 0.625533 |
| supportive care | 0.621812 |
| infectious cause | 0.624793 |
| United States | 0.744619 |
| U.S. Government Printing | 0.726354 |
| original MMWR paper | 0.709727 |
| age group | 0.634798 |
| Global Health Security | 0.745639 |
| Steiner C. Costs | 0.705236 |
| better access | 0.62408 |
| MMWR readers | 0.621741 |
| child mortality | 0.619566 |
| concerted efforts | 0.62632 |
| Healthcare Research | 0.616987 |
| U.S. adults | 0.657631 |
| Ongoing research | 0.618968 |
| civil society | 0.623583 |
| Community-acquired pneumonia | 0.825866 |
| appropriate antimicrobial therapy | 0.727395 |
| et al | 0.729211 |
| international community | 0.623658 |
| systematic analysis | 0.615739 |
|
CLICK HERE |